SEC Filings

Filing Date

Form

Description

Downloads

9/25/15 10-Q Quarterly Report Download SEC Filing to Adobe PDF ico_xbrl
2/24/15 10-Q Quarterly Report Download SEC Filing to Adobe PDF  ico_xbrl
11/19/2014 10-Q Quarterly Report Download SEC Filing to Adobe PDF ico_xbrl
09/22/14 S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Download SEC Filing to Word Download SEC Filing to Adobe PDF  ico_xbrl
08/13/14 NT 10-Q Notification that Quarterly Report will be submitted late Download SEC Filing to Word Download SEC Filing to Adobe PDF  ico_xbrl
07/11/14 10-K Annual Report Download SEC Filing to Word Download SEC Filing to Adobe PDF  ico_xbrl
02/19/14 10-Q Quarterly report [Sections 13 or 15(d)] Acc-no: 0001255294-14-000095(34 Act) Download SEC Filing to Word Download SEC Filing to Adobe PDF ico_xbrl
11/19/13 10-Q Quarterly report [Sections 13 or 15(d)] Acc-no: 0001255294-13-000937 (34 Act) Download SEC Filing to Word Download SEC Filing to Adobe PDF ico_xbrl
08/19/13 10-Q Quarterly report [Sections 13 or 15(d)] Acc-no: 0001255294-13-000668 (34 Act) Download SEC Filing to Word Download SEC Filing to Adobe PDF ico_xbrl
07/01/13 10K 2013  Annual Report 2013 ico_xbrl

News

July 18th, 2017

Rich Pharmaceuticals Announces Collaboration Agreement To Support The Development of Treatments For Parkinson’s Disease: Company Will Receive Cash and Stock and Plans to Pay One Third of the Shares Received in a Dividend to Shareholders
View Release

June 21st, 2017

Rich Pharmaceuticals Announces Principal Doctor for Clinical Trials
View Release

June 8th, 2017

Rich Pharmaceuticals Announces Institutional Review Board Submission
View Release

» View All News

Stock Price